Qubai Hu

491 total citations
15 papers, 423 citations indexed

About

Qubai Hu is a scholar working on Physiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Qubai Hu has authored 15 papers receiving a total of 423 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Physiology, 8 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Qubai Hu's work include Alzheimer's disease research and treatments (12 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Prion Diseases and Protein Misfolding (2 papers). Qubai Hu is often cited by papers focused on Alzheimer's disease research and treatments (12 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Prion Diseases and Protein Misfolding (2 papers). Qubai Hu collaborates with scholars based in United States, Chile and Australia. Qubai Hu's co-authors include George M. Martin, Elena J. Moerman, Galynn Zitnik, Steven L. Bressler, Matthew D. Gray, Walter A. Kukull, Eric B. Larson, Samir S. Deeb, Carol B. Ware and Kimiko Shimizu and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Qubai Hu

15 papers receiving 415 citations

Peers

Qubai Hu
Il‐Sang Yoon United States
Alka Agarwal-Mawal Canada
Cody L. Shults United States
Arames Crameri Switzerland
Francesca-Fang Liao United States
Debora Monteleone Italy
Natalie Landman United States
Yuan-Wen Ge United States
Zan-Chao Liu China
Il‐Sang Yoon United States
Qubai Hu
Citations per year, relative to Qubai Hu Qubai Hu (= 1×) peers Il‐Sang Yoon

Countries citing papers authored by Qubai Hu

Since Specialization
Citations

This map shows the geographic impact of Qubai Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qubai Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qubai Hu more than expected).

Fields of papers citing papers by Qubai Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qubai Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qubai Hu. The network helps show where Qubai Hu may publish in the future.

Co-authorship network of co-authors of Qubai Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Qubai Hu. A scholar is included among the top collaborators of Qubai Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qubai Hu. Qubai Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Snow, Alan D., Gerardo M. Castillo, Beth P. Nguyen, et al.. (2019). The Amazon rain forest plant Uncaria tomentosa (cat’s claw) and its specific proanthocyanidin constituents are potent inhibitors and reducers of both brain plaques and tangles. Scientific Reports. 9(1). 561–561. 55 indexed citations
2.
Alarcón, Marcelo, Qubai Hu, Miguel E. Ávila, et al.. (2012). A novel functional low-density lipoprotein receptor-related protein 6 gene alternative splice variant is associated with Alzheimer's disease. Neurobiology of Aging. 34(6). 1709.e9–1709.e18. 43 indexed citations
3.
Hu, Qubai, et al.. (2011). P2‐529: Identification of Exebryl‐1® and other novel small molecules as tau protein aggregation inhibitors. Alzheimer s & Dementia. 7(4S_Part_14). 5 indexed citations
4.
5.
Zitnik, Galynn, et al.. (2009). Structural and functional characterization of a novel FE65 protein product up‐regulated in cognitively impaired FE65 knockout mice. Journal of Neurochemistry. 112(2). 410–419. 7 indexed citations
6.
Wang, Yan, Ming Zhang, Changjong Moon, et al.. (2009). The APP-interacting protein FE65 is required for hippocampus-dependent learning and long-term potentiation. Learning & Memory. 16(9). 537–544. 25 indexed citations
7.
Snow, Alan D., Joel A. Cummings, Qubai Hu, et al.. (2009). P3‐254: Exebryl‐1: A novel small molecule currently in human clinical trials as a disease‐modifying drug for the treatment of Alzheimer's disease. Alzheimer s & Dementia. 5(4S_Part_14). 15 indexed citations
8.
Zitnik, Galynn, Lin Wang, George M. Martin, & Qubai Hu. (2007). Localizations of endogenous APP/APP-Proteolytic products are consistent with microtubular transport. Journal of Molecular Neuroscience. 31(1). 59–68. 3 indexed citations
9.
Hu, Qubai, et al.. (2005). Endoproteolytic Cleavage of FE65 Converts the Adaptor Protein to a Potent Suppressor of the sAPPα Pathway in Primates. Journal of Biological Chemistry. 280(13). 12548–12558. 26 indexed citations
10.
Martin, George M., et al.. (2005). A Dominant Role for FE65 (APBB1) in Nuclear Signaling. Journal of Biological Chemistry. 281(7). 4207–4214. 50 indexed citations
11.
Hu, Qubai, Mark G. Hearn, Kimiko Shimizu, et al.. (2003). Isoform‐specific knockout of FE65 leads to impaired learning and memory. Journal of Neuroscience Research. 75(1). 12–24. 61 indexed citations
12.
Maezawa, Izumi, et al.. (2002). Alterations of chaperone protein expression in presenilin mutant neurons in response to glutamate excitotoxicity. Pathology International. 52(9). 551–554. 5 indexed citations
13.
Hu, Qubai, et al.. (2000). Broadly altered expression of the mRNA isoforms of FE65, a facilitator of beta amyloidogenesis, in Alzheimer cerebellum and other brain regions. Journal of Neuroscience Research. 60(1). 73–86. 26 indexed citations
14.
Hu, Qubai, Walter A. Kukull, Steven L. Bressler, et al.. (1998). The human FE65 gene: genomic structure and an intronic biallelic polymorphism associated with sporadic dementia of the Alzheimer type. Human Genetics. 103(3). 295–303. 58 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Il‐Sang Yoon Breakdown of academic impact, for papers by Alka Agarwal-Mawal Breakdown of academic impact, for papers by Cody L. Shults Breakdown of academic impact, for papers by Arames Crameri Breakdown of academic impact, for papers by Francesca-Fang Liao Breakdown of academic impact, for papers by Debora Monteleone Breakdown of academic impact, for papers by Natalie Landman Breakdown of academic impact, for papers by Yuan-Wen Ge Breakdown of academic impact, for papers by Zan-Chao Liu
Rankless by CCL
2026